• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Am J Physiol Lung Cell Mol Physiol . ADAM10 Partially Protects Mice against Influenza Pneumonia by Suppressing Specific Myeloid Cell Population

tetano

Editor, Senior Moderator
Am J Physiol Lung Cell Mol Physiol


. 2021 Sep 15.
doi: 10.1152/ajplung.00619.2020. Online ahead of print.
ADAM10 Partially Protects Mice against Influenza Pneumonia by Suppressing Specific Myeloid Cell Population


Satoshi Okamori[SUP] 1 2 [/SUP], Makoto Ishii[SUP] 1 [/SUP], Takanori Asakura[SUP] 1 [/SUP], Shoji Suzuki[SUP] 1 [/SUP], Ho Namkoong[SUP] 1 [/SUP], Shizuko Kagawa[SUP] 1 [/SUP], Ahmed E Hegab[SUP] 1 [/SUP], Kazuma Yagi[SUP] 1 [/SUP], Hirofumi Kamata[SUP] 1 [/SUP], Tatsuya Kusumoto[SUP] 1 [/SUP], Takunori Ogawa[SUP] 1 [/SUP], Hayato Takahashi[SUP] 3 [/SUP], Masaki Yoda[SUP] 4 [/SUP], Keisuke Horiuchi[SUP] 4 5 [/SUP], Naoki Hasegawa[SUP] 6 [/SUP], Koichi Fukunaga[SUP] 1 [/SUP]



Affiliations

Abstract

The influenza virus infection poses a serious health threat worldwide. Myeloid cells play pivotal roles in regulating innate and adaptive immune defense. A disintegrin and metalloproteinase (ADAM) family of proteins contribute to various immune responses; however, the role of ADAM10 in influenza virus infection remains largely unknown. Herein, we investigated its role, focusing on myeloid cells, during influenza virus infection in mice. Adam10[SUP]flox/flox[/SUP]/Lyz2-Cre (Adam10[SUP]ΔLyz2[/SUP]) and control Adam10[SUP]flox/flox[/SUP] mice were intranasally infected with 200 plaque-forming units of influenza virus A/H1N1/PR8/34. Adam10[SUP]ΔLyz2[/SUP] mice exhibited a significantly higher mortality rate, stronger lung inflammation, and a higher virus titer in the lungs than control mice. Macrophages and inflammatory cytokines such as TNF-α, IL-1b, and CCL2 were increased in bronchoalveolar lavage fluid from Adam10[SUP]ΔLyz2[/SUP] mice following infection. CD11b[SUP]+[/SUP]Ly6G[SUP]-[/SUP]F4/80[SUP]+[/SUP] myeloid cells, which had an inflammatory monocytes/macrophages-like phenotype, were significantly increased in the lungs of Adam10[SUP]ΔLyz2[/SUP] mice. Adoptive transfer experiments suggested that these cells likely contributed to the poorer prognosis in Adam10[SUP]ΔLyz2[/SUP] mice. Seven days after infection, CD11b[SUP]+[/SUP]Ly6G[SUP]-[/SUP]F4/80[SUP]+[/SUP] lung cells exhibited significantly higher arginase-1 expression levels in Adam10[SUP]ΔLyz2[/SUP] mice than in control mice, while an arginase-1 inhibitor improved the prognosis of Adam10[SUP]ΔLyz2[/SUP] mice. Enhanced granulocyte-macrophage colony-stimulating factor (GM-CSF)/GM-CSF receptor signaling likely contributed to this process. Collectively, these results indicate that myeloid ADAM10 protects against influenza virus pneumonia and may be a promising therapeutic target.

Keywords: ADAM10; GM-CSF; inflammatory monocytes; influenza.
 
Back
Top Bottom